Overview of Perindopril
Quick Facts
| Property | Description |
|---|---|
| Active ingredient | Perindopril (as Erbumine or Arginine salt) |
| Form | Tablet |
| Pharmacological class | Angiotensin-Converting Enzyme (ACE) Inhibitor |
| Common purpose | Lowering of high blood pressure |
| Origin | Synthetic (Dipeptide-derived) |
What Type of Medicine is Perindopril?
Perindopril is a synthetic, prescription-only drug that belongs to the Angiotensin-Converting Enzyme (ACE) Inhibitor pharmacological class. This classification, which is clinically recognized for cardiovascular efficacy, indicates its primary function is centered on modulating the Renin-Angiotensin-Aldosterone System (RAAS), a hormonal cascade critical to regulating blood pressure and fluid balance in the body. The substance itself is classified as a dipeptide-derived prodrug, meaning it requires metabolic conversion in the liver into its active form, perindoprilat, to become therapeutically effective. ACE inhibitors are widely utilized for managing cardiovascular risk factors.
Composition and Form: Perindopril Erbumine or Arginine Tablet
The active ingredient in this medicine is the Perindopril chemical moiety, which is primarily formulated for stability and absorption as either the Perindopril Erbumine or Perindopril Arginine salt. The medicine is a single-ingredient product delivered in a solid tablet form, intended for oral administration. The long-acting nature of the drug distinguishes it from shorter-acting ACE inhibitors. While Perindopril is the active ingredient, popular commercial names for products containing this INN include Coversyl and Aceon, which are structurally identical at the core therapeutic level. The different salt variations are pharmaceutical distinctions that address formulation stability and handling, not the core physiological action of the drug.
What is the General Purpose of an ACE Inhibitor?
The general purpose of administering an ACE inhibitor like Perindopril is to achieve a controlled and sustained lowering of blood pressure, thereby reducing overall mechanical strain on the heart and the circulatory system. By performing ACE inhibition, Perindopril causes vasodilation (blood vessel widening) because it reduces the synthesis of the powerful natural vasoconstrictor, Angiotensin II. This primary physiological effect, combined with a slight reduction in the body's retention of salt and water, ensures smoother, less strenuous blood circulation, which is the core benefit provided by this class of medication. The medication acts on the vascular system.
Regulatory References
